Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-box transcription factor 3 (TBX3) is a critical member of the T-box family of transcription factors, defined by a highly conserved DNA-binding domain. It functions primarily as a transcriptional repressor, playing essential roles in embryonic development, including the formation of the heart's conduction system, limbs, and mammary glands (UniProt: O15119). In the context of the nervous system, TBX3 is involved in regulating the balance between neural progenitor proliferation and differentiation by binding to and repressing neuronal gene regulatory regions, particularly in the hypothalamus (PubMed: 28604677). Overexpression of TBX3 is a hallmark of several malignancies, including breast cancer and melanoma, where it contributes to tumor progression, metastasis, and evasion of cellular senescence (PubMed: 25103495). Conversely, loss-of-function mutations in the TBX3 gene lead to Ulnar-mammary syndrome, a pleiotropic developmental disorder (NIH: GeneReviews). Although TBX3 is a high-priority target in oncology due to its role in promoting the cancer stem cell phenotype, direct small-molecule inhibition remains technically challenging, with current research focusing on indirect modulation of its upstream regulators.
Acts as a transcriptional repressor by binding to specific DNA sequences known as T-elements in the regulatory regions of target genes, thereby inhibiting their transcription and downstream protein expression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-box transcription factor 3 (TBX3).